Navigation Links
M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market
Date:4/12/2012

LONDON, April 12, 2012 /PRNewswire/ --

- - Finger Vein Identity Management Solution a Perfect Fit for the M2SYS Biometrics Product Portfolio - -

Hitachi Europe Ltd. and M2SYS Technology today announced that they have entered into a strategic partnership making M2SYS Hitachi's primary Value Added Reseller in North America for the H1 Biometric Finger Vein scanner.

Biometric Finger Vein identity management scanning technology was developed by Hitachi to provide safer and more secure authentication for access control and other identification purposes. Using near infrared light to detect and capture the vein pattern inside a finger, the H1 Finger Vein scanner is a unique solution for cost-effective identity management. Finger Vein biometric identity management technology is safe because vein patterns are internal to the body so forge them is virtually impossible, effectually making counterfeiting improbable and providing a high level of security.

Michael Trader, president of M2SYS said: "M2SYS has made a name by providing specialty enterprise-ready biometric software and hardware solutions and Hitachi's H1 Finger Vein scanners are a perfect fit for us. By adding this to our portfolio of biometric solutions, we will be able to better customize our offerings to the specific needs of our customers across the globe."

Ravi Ahluwalia, Deputy General Manager, Head of Identity Management Group, Information Systems Group of Hitachi Europe said: "We are very pleased to be partnering with a renowned company like M2SYS. Their range of specialized products in the biometrics area is a perfect fit. This strategic partnership provides a key benefit to M2SYS's customers by giving them access to proven, easy-to-use identity management technology."

About Hitachi Europe Ltd.

Hitachi Europe Ltd., is a wholly owned subsidiary of Hitachi, Ltd., Japan. Headquartered in Maidenhead, UK, it has operations in 12 countries across Europe, the
'/>"/>

SOURCE Hitachi Europe Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform(TM) That Offers Unparalleled Flexibility to End-Users
2. Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform™ That Offers Unparalleled Flexibility to End-Users
3. Qqest Teams Up With M2SYS to Add Biometric Technology at the Desktop to TimeForce Time and Attendance System
4. Qqest Teams Up With M2SYS to Add Biometric Technology at the Desktop to TimeForce Time and Attendance System
5. M2SYS Biometric Software Solution Selected By GHG Corporation
6. M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers
7. ACS Technologies(TM) Selects M2SYS for Innovative Biometric Software
8. M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers
9. InvoTech Selects M2SYS Technology for Leading-Edge Fingerprint Software Solution
10. New technology tracks sparrow migration for first time from California to Alaska
11. Powerful sequencing technology decodes DNA folding pattern
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
(Date:12/10/2014)... been here before: you desperately need to sign into your online ... answer to your secret question. What,s your dog,s birthday? Who was ... , a digital infrastructure security company, launches the app ... with usernames, passwords and PINs – 1U TM . ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... BOULDER--The use of prescribed burns to manage Western ... footprint. A new study finds that such burns, often ... bigger trees, release substantially less carbon dioxide emissions than ... prescribed burns can be an important piece of a ...
... DC, March 16, 2010 A new study ... research institutions states that forest protection offers one ... to combat climate change. The study, "Indigenous Lands, ... in PLoS Biology , a peer-reviewed scientific ...
... UCSF researchers have discovered that a key cellular defect ... can lead to cancer susceptibility. The scientists also found ... in correcting this defect. According to the study ... fight against cancer and could affect treatment of lymphoma ...
Cached Biology News:Prescribed burns may help reduce US carbon footprint 2Prescribed burns may help reduce US carbon footprint 3Study highlights forest protected areas as a critical strategy for slowing climate change 2Blocking cancer in its path: New cellular defect discovered 2Blocking cancer in its path: New cellular defect discovered 3
(Date:1/22/2015)... Wilmington, DE (PRWEB) January 22, 2015 ... the Pistoia Alliance, which helps companies check the legal ... set to expand to China. , As their ... companies are globally adopting software solutions built as a ...
(Date:1/22/2015)... Nueva Jersey , 22 de enero de 2015 ... Research abre hoy su llamada a nominaciones para 2015. ... científica ha hecho, o tiene el potencial para hacer, ... Las nominaciones se aceptarán hasta el 15 de marzo ...
(Date:1/22/2015)... , a precision medicine software company that has developed a ... genomic, imaging and other biomedical data in research and clinical ... CEO of Aspera, an IBM Company, to its board as ... "We are pleased to welcome Michelle to ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... N.C., June 10 Campbell Alliance, the leading,management ... today announced that executives from the firm,s Trade ... Business Intelligence,(CBI) 4th Annual Commercial Contracts and Chargeback ... June 19-20, 2008, at,the Hyatt Regency Philadelphia at ...
... (OTC,Bulletin Board: AGGX.OB) a New York-based biotechnology company, ... anti-angiogenic drugs, announced the,appointment of William Garland PhD ... La Roche, Inc., has directed research and,development programs ... such as,Centaur Pharmaceuticals, Atairgin Technologies, Lpath Therapeutics, Inc.,(LPTN.OB) ...
... Therapeutics Inc. is extremely,pleased to announce the initiation ... IAP,("Inhibitor of Apoptosis Protein") inhibitor, HGS1029 (formerly AEG40826),as ... This small,molecule IAP inhibitor was developed by Aegera ... HGSI ) for oncology development in December 2007. ...
Cached Biology Technology:Campbell Alliance Trade and Distribution Practice to Speak at CBI's Commercial Contracts and Chargeback Management Conference 2Campbell Alliance Trade and Distribution Practice to Speak at CBI's Commercial Contracts and Chargeback Management Conference 3AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 2AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 3Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment 2
Request Info...
Mouse monoclonal [3G131] to Desmoglein 1 ( Abpromise for all tested applications). entrezGeneID: 1828 SwissProtID: Q02413...
TCP-1 alpha (H-110)...
Synphilin 1 Immunogen: Synthetic peptide corresponding to residues S(829) L E L N G E K D K D K G R T L Q R T(847) of human Synphilin 1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: